Bioarctic Ab Is A Swedish Biotechnology Company Based In Stockholmfounded In 2000The Company Specializes In Developing Biological Drugs For Central Nervous System Disordersparticularly Neurodegenerative Diseases Like Alzheimerae S And Parkinsonae Sbioarctic Utilizes Its Proprietary Antibody Technology Platform To Create Therapeutic Monoclonal Antibodies That Effectively Penetrate The Blood Brain Barrier The Company Is Advancing Several Key Productsincluding Lecanemaban Anti Amyloid Antibody For Alzheimerae S Currently In Phase 3 Trialsand Exidavnemabwhich Is In Phase 2 Targeting Neurodegenerative Pathwaysbioarctic Also Has A Pipeline Of Preclinical Candidates And Discovery Stage Projects Aimed At Addressing Parkinsonae S Diseasecollaborations With Partners Like Eisai And Abbvie Enhance Its Research And Development Effortsfocusing On Late Stage Clinical Trials And Exploratory Programs For Cns Disorders
